Announced Fri, 10 Apr · 11:11 IST
NSE seeks clarification on $12B Organon deal news report
Regulatory & Legal
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.6%1-day move
₹1715.00
prior close
₹1640.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.5-0.2-0.2-3.6-1.2-1.2-2.3-2.9-2.7+6.0+9.3+4.2+12.7
Up moveDown movePending
AI summary
NSE has asked Sun Pharma to clarify a recent news report titled 'Sun Pharma slips nearly 4% after $12 billion Organon deal enters final stage.' The company's response is awaited. No details on the deal or clarification have been provided yet.
Likely market impact
Awaiting company's response; near-term stock volatility possible as deal clarity emerges.